Loading…

Twelve-month kinetics of circulating fibrosis-linked microRNAs (miR-21, miR-29, miR-30, and miR-133a) and the relationship with extracellular matrix fibrosis in dilated cardiomyopathy

A single measurement of any biomarker may not reflect its full biological meaning. The kinetics of fibrosis-linked microRNAs and their relationship with extracellular matrix (ECM) fibrosis in dilated cardiomyopathy (DCM) have not been explored. We evaluated 70 consecutive DCM patients (48 ±12.1 year...

Full description

Saved in:
Bibliographic Details
Published in:Archives of medical science 2022, Vol.18 (2), p.480-488
Main Authors: Rubiś, Paweł, Totoń-Żurańska, Justyna, Kołton-Wróż, Maria, Wołkow, Paweł, Pitera, Ewelina, Wiśniowska-Śmiałek, Sylwia, Dziewięcka, Ewa, Garlitski, Ann, Podolec, Piotr
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A single measurement of any biomarker may not reflect its full biological meaning. The kinetics of fibrosis-linked microRNAs and their relationship with extracellular matrix (ECM) fibrosis in dilated cardiomyopathy (DCM) have not been explored. We evaluated 70 consecutive DCM patients (48 ±12.1 years, left ventricular ejection fraction 24.4 ±7.4%). All patients underwent right ventricular endomyocardial biopsy in order to quantify ECM fibrosis and measure collagen volume fraction (CVF). Circulating microRNAs (miR-21-5p, miR-29b, miR-30c-5p, and miR-133a-3p) were measured with quantitative polymerase chain reaction (PCR) at baseline and at 3 and 12 months. Based on the biopsy results, two groups of patients were identified: with ( = 24, 34.3%) and without ( = 46, 65.7%) ECM fibrosis. Except for a single measurement of miR-29b at 3 months (DCM with fibrosis: 6.03 ±0.72 vs. DCM without fibrosis: 6.4 ±0.75 ΔCq; < 0.05), baseline, 3- and 12-month kinetics of microRNAs did not differ between the two groups. Moreover, 12-month microRNA kinetics did not differ in patients with new-onset DCM (duration < 6 months; = 35) and chronic DCM (> 6 months; = 35). Only miR-29 at 3 months correlated with CVF ( = -0.31; < 0.05), whereas other microRNAs did not correlate with CVF either at 3 or at 12 months. Regardless of ECM fibrosis status or duration of the disease, 12-month patterns of circulating microRNAs are similar in DCM. Correlations between microRNAs, measured at 3 and 12 months, are lower than expected. In this study, regardless of the time point, circulating microRNAs were not able to differentiate between DCM patients with versus without fibrosis.
ISSN:1734-1922
1896-9151
DOI:10.5114/aoms.2019.89777